Objective-To determine whether dietary treat-> ment has a similar antihypertensive effect to convenKr> tional drug treatment while being superior to drugs in improving serum lipid concentrations in obese men with mild hypertension. Design-Six week run in period followed by randomisation to either diet or drug treatment groups for one year.
The alternative treatment modalities concern various dietary factors. Obesity is common among people with hypertension, and weight reduction is generally agreed to lower blood pressure. '4 Restriction of sodium intake and of excess alcohol consumption have also been advocated. ' 24 The main shortcoming of these recommendations is the lack of knowledge of whether such dietary programmes have the same favourable effect on morbidity associated with hypertension as do antihypertensive drugs. Long term studies comparing non-pharmacological programmes with conventional drug treatment are therefore necessary, and they must consider not only feasibility and antihypertensive measures but also effects on metabolic factors and structural changes in the cardiovascular system due to hypertension.
In the present study we investigated and treated obese men with mild hypertension for one year. The objectives were to create an effective dietary programme; to evaluate its feasibility in clinical practice; and to analyse whether such treatment has a similar antihypertensive effect as conventional drugs while being superior to drug treatment in improving other risk factors such as serum lipid concentrations.
The intervention was based on principles known to lower blood pressure: weight reduction, mainly by reducing intake of saturated fat'"; restriction of sodium intake' 24; a aecreased excess consumption of alcohol' 24; and increased intake of polyunsaturated fat' and potassium. 4 
Methods
The participants were men aged 40-69 years with obesity (defined as a body mass index -266) and primary mild hypertension. Eligibility criteria were diastolic blood pressure of90-104 mm Hg for untreated patients and -< 95 mm Hg for patients being treated with antihypertensive drugs. The lower limit for treated patients was chosen to avoid participants having severe hypertension after drug withdrawal. Exclusion criteria were angina pectoris, previous myocardial infarction, heart After an initial evaluation to determine eligibility the patients went through a run in procedure for six weeks, during which blood pressure and heart rate were measured weekly as described below. All antihypertensive drugs were discontinued at the initial visit. The final criterion for entry was a mean diastolic blood pressure at the last three recordings of 90-104 mm Hg; this was also regarded as the baseline blood pressure. Consent was obtained from the patients after they had been given oral and written information about the study. They were randomly allocated to a treatment group by their birth date: patients born on even dates were allocated to the diet group and those born on uneven days to the drug treatment group.
Blood pressure was monitored every month during the study. The patients in both groups met the doctor (AB or BF) six weeks before and at randomisation and three, six, and 12 months thereafter. If diastolic blood pressure was :-105 mm Hg at two consecutive measurements or -110 mm Hg at any time drug treatment was given and the patient was excluded from the study. The occurrence of events defined above as exclusion criteria also prevented further participation in the study.
TREATMENT GOALS AND METHODS
The dietary programme aimed at reducing body weight at least 5%, restricting sodium intake to <i95 mmol/day, decreasing alcohol intake in patients consuming -250 g/week, increasing the ratio of polyunsaturated to saturated fat in the diet to .-05, and increasing potassium intake to at least 100 mmol/day.
Every patient had an individual treatment goal that was decided in cooperation with the doctor. After dietary intake had been assessed the patients met the dietitian during the first month and after three, six, and 12 months. Three group meetings lasting for three hours were held during the first two months; five to 10 patients participated with their spouses, the dietitian, and one doctor.
Nutritional counselling was based on conventional principles aiming at a weight loss of 0-5 kg/week until a stable weight was reached. Fat intake was recommended to be below 30% of energy requirements with a parallel increase in complex carbohydrates to 50% and protein for the remainder. Meal patterns, basic nutrition, menu planning, and food selection and preparation were discussed, and the medical rationale for treatment was explained. The patients were taught to monitor their salt intake by recording the chloride concentration in urine on a dipslide test (Saltex, Miles Laboratories, Elkhait, Indiana). Every patient recorded body weight at home once a week. Determinations of body mass, urinary concentrations of sodium and potassium, and blood pressure were used as feedback to motivate the patients. Adherence to diet was also checked with diet records. Individual counselling on alcohol intake took place when participants met their doctor in the hypertension outpatient unit.
The pharmacological regimen was atenolol 50-100 mg once daily as first line treatment and bendrofluazide 2 5 mg daily and nifedipine 10-20 mg twice daily. Other agents and combinations were also allowed in case of adverse side effects or insufficient control of blood pressure.
MEASUREMENTS
Blood pressure was measured by specially trained nurses using a Hawksley random zero mercury sphygmomanometer with a cuff of appropriate size. Systolic blood pressure was recorded as appearance of the first sound and diastolic as disappearance of the last sound. The patients rested in the recumbent position for five minutes and the mean of two recordings was used. Heart rate was then measured by palpation of the radial pulse. The measurements were always made in the morning. In the drug treatment group the drugs were taken as usual on examination days-that is, in the early morning. After completing the study the patients were followed every second month and blood pressure was routinely measured. 8 Body weight was recorded on a level balance scale to the nearest 0-1 kg with the patient wearing trousers but not shoes, and body mass index calculated as weight (kg)/(height (m))2.
Four day diet records with additional diet histories were assessed at baseline, six, and 12 months in the diet group. Those in the drug treatment group were not asked to record their eating habits until the end of the study so that changes would not be induced in their diet. The invasive heart examinations and plethysmography of the forearm obtained at baseline and at the end of the study will be reported separately.
The study was approved by the ethical committee of the faculty of medicine, Gothenburg University.
STATISTICAL METHODS
In planning the study we considered a difference in diastolic blood pressure of 5 mm Hg between the groups to be clinically important and assumed a standard deviation of 6 diet records obtained at baseline in the diet group and after 12 months in both groups. The dietary programme reduced energy intake (1800 (SDI900) kJ, p<O0OOOl) by decreasing the amount of fat and protein consumed by 8 (6)% of energy intake (p<O0OOOl) and 3 (3)% of energy intake (p<O OOO 1) respectively while increasing the intake of carbohydrates by 5 (7)% of energy intake (p=00014 Table IV shows blood pressure and heart rate during treatment. Systolic blood pressure decreased by 4 (11) mm Hg in the diet group and by 16 (12) mm Hg in the drug group (p=0 0003). The corresponding values for diastolic blood pressures were reductions of 3 (6) and 11 (6) mm Hg, (p=00OOl). Heart rate decreased by 3 (8) beats/min in the diet group and 9 (8) beats/min in the drug treatment group (p=-00022).
A diastolic blood pressure <90 mm Hg was attained by 29% (9/3 1) of patients in the diet group and 73% (22/ 30) (7) 68 (10) 60 (8) 9 146 (18) 139 (15) 92 (7) 89 (8) 67 (11) 61 (8) 10 148 (16) 139 (14) 94 (6) 85 (6) 71 (11) 60 (7) 1 1 146 (15) 140 (16) 92 (6) 86 (7) 67 (8) 60 (8) 12 147 (15) 140 (16) 92 (7) 86 (8) 67 (8) -lOto-6 16 in the drug treatment group had received antihypertensive treatment before the study. During the trial they reduced their diastolic blood pressure by 2 (6) and 10 (7) mm Hg respectively, the exact difference being -8 8 mm Hg. The patients who had not taken drugs (nine in the group treated with diet and 14 in the group given drug treatment) had reductions in diastolic blood pressure of 6 (4) and 12 (6) mm Hg, respectively, a difference of -6 mm Hg. The difference between the differences was -3 (6) mm Hg, which was not significant (95% confidence interval -9 to 3 mm Hg). Within the diet group, however, previous antihypertensive treatment was associated with a significantly lower decrease in diastolic blood pressure than was no previous treatment (p=0 03).
Electrocardiograms of 10 patients in the diet group and four in the drug group showed left ventricular hypertrophy. In these patients mean diastolic blood pressure decreased by 2 (8) and 15 (8) mm Hg respectively and in the remaining patients by 4 (5), and it decreased by 4 (5) mm Hg in the diet group and 11 (6) mm Hg in the drug treatment group. When the differences were compared the final difference was -6 (6) mm Hg, which was not significant (95% confidence interval -14 to 2 mm Hg).
In the diet group the change in diastolic blood pressure during the study was not significantly correlated to baseline body mass index (rs=0 06), weight loss during treatment (r,=0 28), change in sodium output (r,=0 31), or change in alcohol intake (rs= 0-14).
FOLLOW UP
The patients in the diet group were followed up every second month for a mean of 14 (range 4-21) months after treatment (n = 31). Mean body weight increased by 2 6 (3 0) kg (p<0 001). Five (16%) had a diastolic blood pressure below 90 mm Hg and were taking no antihypertensive drugs.
Discussion
The first aim of this study was to design a dietary programme and evaluate its effectiveness and feasibility. The cornerstone of the programme was weight reduction, which is generally considered to be the most effective change in lifestyle.2 '4 Our definition of obesity compared well with that of other investigators'5 6 as well as with the recommendations of a consensus development conference.6 A goal of at least 5% reduction in body weight was expected to cause a mean decrease in diastolic blood pressure of 6-7 mm Hg 1920 and is in line with the intervention goal in another well known study.'6 To our knowledge there have been two controlled studies of untreated patients lasting for a year or more that used diet in treating hypertension, both from the United States: the dietary intervention study in hypertension and the hypertension control programme.'5 16 The average weight loss in these patients was 4 0 and 1-8 kg respectively, compared with 7-6 kg in our study. Moreover, a reduction in body weight of 5% or more was attained by 84% of patients in our study compared with 46% and 30% in the two other reports. On the basis of our previous experience'0 we defined an intervention goal for sodium intake of <95 mmol/24 h; this was higher than in the other two studies (70 and 74 mmol/24 h, respectively).'5 16 Our measurements of urinary creatinine excretion indicated that the patients had collected urine as instructed; the mean daily output of sodium decreased by 42 mmol/24 h in this trial compared with 44-59 and 60 mmol/24 h. 15 16 The association between excessive alcohol consumption and hypertension is well documented, and a reduced intake is strongly advocated.' 24 We used roughly the same treatment goals as did the hypertension control programme. Taking into account the uncertain validity of self reporting we found a low proportion of high consumers of alcohol; we did not succeed in changing their consumption. Neither did the American study report significant changes in this respect. 6 Though there is no consistent evidence of their antihypertensive effects,24 we also included increases in dietary potassium and the ratio of polyunsaturated to saturated fat in the programme. These measures are, however, in line with general food recommendations that aim at increasing the consumption of fruit, vegetables, and polyunsaturated fat and decreasing the intake of saturated fat; this is known to lower serum cholesterol concentrations.2' The potassium intake, as measured from daily urinary excretion, did not increase. The mean ratio of polyunsaturated to saturated fat increased above 0 5 and was attained by a third of the patients. This estimation was, however, based on periodic diaries, which may not adequately reflect long term patterns. Even so, there was an acceptable concordance between the reduction in reported total intake of energy and observed mean weight loss. According to their diet records the patients had also followed the recommendations on intake of nutritients, decreasing their intake of fats and increasing their intake of carbohydrates. Thus The higher proportion of patients with more severe forms of hypertension in the diet group may have weakened the effect of treatment in that group. The groups were not dissimilar in terms of average blood pressure at baseline, but more patients in the diet group had evidence of left ventricular hypertrophy. The statistical analysis, however, showed that this difference between the groups had no great influence on diastolic blood pressure at the end of the study. The diet group also contained more patients previously treated for hypertension (22 v 16) , which was associated with a poorer response to intervention than in those not treated previously. The observation is in line with studies showing that hypertension recurs in most patients within one year of stopping drugs. Further analysis, however, did not show any difference between the groups in the influence of previous antihypertensive treatment. The hypertension control programme which examined only hypertensive patients after drug withdrawal and with the same end points as we used, had a success rate of 69% after one and 39% after four years,'6 compared with 29% after one and 16% after two years in our patients. Even when the 95% confidence interval of 14% to 48% for our value at one year is considered there is a clear difference in results, despite our greater success in obtaining weight reduction.
In this context it may be pertinent to compare our results with the often cited studies by Reisin et al17 and MacMahon et al'6. Reisin et al showed that an average weight loss of 8 8 kg during four months was associated with a mean decrease in blood pressure of 26/20 mm Hg.'7 MacMahon et al reported that blood pressure decreased a mean of 13/10 mm Hg at the end of five months of a diet regimen that led to a weight loss of 7 4 kg, which was superior to placebo and to metoprolol 200 mg daily. '6 In contrast, we obtained a mean reduction of 7 6 kg in body weight and of 4/3 mm Hg in blood pressure. These differences may be explained by differences in patient selection, proportion of participants previously treated, run in procedure, type of diet, establishing a new steady state, and, above all, duration of the study. Our patients were not more obese, however, nor were our intervention goals for weight reduction too conservative in comparison with these studies. Finally, one randomised, controlled study showed no antihypertensive effect of weight reduction, 2 lending support to our findings that weight reduction may not effectively lower blood pressure. In addition, our follow up more than two years after treatment indicated a further, important decrease in the number of patients remaining normotensive with non-pharmacological treatment.
The study was designed to test the impact of a comprehensive diet programme and not the effect of single factors. The basis for analysis was comparisons between groups, but within group analysis was carried out to examine whether varying individual responses in blood pressure to the diet could be related to specific characteristics of the patients or to their compliance. This variability could not be explained by the initial degree of obesity or different degrees of reduction in body weight, sodium intake, or alcohol consumption.
Treatment with diet resulted in an overall beneficial effect on concentrations of low density lipoprotein and high density lipoprotein cholesterol, the ratio of total cholesterol to high density lipoprotein cholesterol, and concentrations of triglycerides. Treatment with antihypertensive drugs, mainly selective f1l blockade, was associated with unfavourable changes in the opposite direction. All these findings accord with those of previous reports." '6 7 24 The present study comparing the effects of a multifactorial nutritional programme and conventional antihypertensive drug treatment on obese hypertensive men is a small study, and its results are not generally applicable to the hypertensive population as the patients were not randomly selected; this is also indicated by the low drop out rate. The results may, however, be applied to treating well motivated patients. The experimental design was close to everyday clinical practice in that the aim of treatment was to obtain normal blood pressure according to generally accepted recommendations"2and with access to all common antihypertensive drugs. The study showed that diet treatment was not as effective as drug treatment in lowering blood pressure, but diet treatment had beneficial effects on serum lipid concentrations, whereas antihypertensive drugs showed adverse effects. The true prognostic importance of combined changes in blood pressure and serum lipids remains to be determined.
Introduction
Subarachnoid haemorrhage is relatively uncommon, with a mortality of one in three.' Health care workers in primary care often have little experience of patients who have had a haemorrhage. Many papers have been published on subarachnoid haemorrhage, but virtually none is of use to those who are concerned in aftercare. Moreover, it may take many years for a representative sample of patients to pass through a general practice. The need for better information became clear to us while conducting a follow up study of 100 patients recovering from a subarachnoid haemorrhage. We found that when patients were discharged back to the care of their general practitioners many of the doctors were unable to comment on the minor problems their patients described and often referred patients to the neurosurgeon-a lengthy route for a few words of reassurance, which was sometimes the only treatment required.
Trying to learn about subarachnoid haemorrhage from current publications would only confuse the nonspecialist. Though earlier studies tended to report excellent recovery rates, more recent researchers claim that the closer they looked the more they found in terms of impaired intellect and impoverished quality of life."4 In these investigations, based on retrospective group studies, the patient was often assessed many years after the event: thus the results have a limited application in treating patients in the first few months of convalescence.
We describe the implications for the aftercare of patients who have had a subarachnoid haemorrhage in a one year prospective follow up study of a representative sample of patients at the South East Thames regional neurosurgical unit, Brook Hospital, London.
Patients and methods
One hundred patients with a diagnosis of subarachnoid haemorrhage constituted the experimental group. Each patient was assessed three times: at initial discharge from hospital, at three months, and at one year. The assessment consisted of a two hour examination of cognitive functions using a test battery derived from the psychology department of the National Hospital for Nervous Diseases, London.6 A semistructured interview with a close friend or relative of the patient (often a spouse) was carried out at each assessment, and questionnaires on mood and behaviour were also used.6 The most valuable source of information was found to be the semistructured interview, which could be tailored to suit the idiosyncrasies of each patient. The contribution of the illness to the overall quality of life (work and social and domestic life) was judged from these data.
Results
Of the 100 patients with subarachnoid haemorrhage who entered the study, 17 were lost during their first year through ineligibility (because of the need for further surgery, a previous head injury, relevant 
